# Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/antidiabetic-drugs-in-parkinson-s-disease-a-comprehensive-meta-analysis-on/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amr M. Abou Elezz,Kareem Khalefa,Ahmed Farid Gadelmawla,Youssef A. Khattab,Mohamed Abo Zeid |
| Citations | 2 |
| DOI | 10.1007/s10787-025-01873-0 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s10787-025-01873-0.pdf |
| OpenAlex ID | https://openalex.org/W4412956692 |
| PMID | 40762930 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Kareem Khalefa](https://scholariq.org/researchers/kareem-khalefa/)

## Paper primary topic

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

## Paper topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.